Oei, Shiao Li http://orcid.org/0000-0002-5772-550X
Thronicke, Anja http://orcid.org/0000-0002-6421-8290
Grieb, Gerrit
Schad, Friedemann http://orcid.org/0000-0002-6928-6209
Groß, Jessica
Clinical trials referenced in this document:
Documents that mention this clinical trial
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data
https://doi.org/10.1007/s12282-023-01494-x
Assessment of integrative non-pharmacological interventions and quality of life in breast cancer patients using real-world data
https://doi.org/10.1007/s12282-020-01193-x
Evaluation of quality of life in lung cancer patients receiving radiation and Viscum album L.: a real-world data study
https://doi.org/10.1186/s13014-023-02234-3
Article History
Received: 15 March 2023
Accepted: 9 August 2023
First Online: 16 August 2023
Declarations
:
: FS reports grants from Helixor Heilmittel GmbH (travel costs and honoraria for speaking), grants from AstraZeneca (travel costs and honoraria for speaking), grants from Abnoba GmbH, and grants from Iscador AG, outside the submitted work. JG reports grants from Roche, Siemens, mte, and Celgene (travel costs and honoraria for speaking), outside the submitted work. The other authors have declared that no competing interests exist. No payment was received for any other aspects of the submitted work. There are no patents, products in development or marketed products to declare. There are no other relationships/conditions/circumstances that present a potential conflict of interest.